Loading...
26 Hyperglycemics Reports
Study Period: 2019- 2029
Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S
Study Period: 2018 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb
Study Period: 2018 - 2029
Countries Covered: France, Germany, Italy, Spain, United Kingdom, Russia
Major Players: Bristol Myers Squibb, AstraZeneca, Boehringer Ingelheim, Janssen Pharmaceuticals, Eli Lilly and Company
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Latin America, Asia Pacific
Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas
Study Period: 2019 - 2029
Countries Covered: United States, Canada
Major Players: Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Astellas
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Abbott, Sanofi , Mylan Inc, Lupin, Aurobindo Pharma
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company
Study Period: 2019 - 2029
Countries Covered: Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand
Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis
Study Period: 2019- 2029
Countries Covered: United States, Canada
Major Players: Sanofi Aventis, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Merck & Co., Inc.
Study Period: 2018 - 2029
Countries Covered: Mexico, Brazil
Major Players: Bristol-Myers Squibb, Boehringer Ingelheim, Merck and Co., Sanofi Aventis, Glenmark Pharmaceuticals
Study Period: 2019 - 2029
Countries Covered: United States, Canada
Major Players: Sanofi S.A., Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc, Biocon Limited
Study Period: 2019 - 2029
Countries Covered: Mexico, Brazil
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Pfizer
Study Period: 2018 - 2029
Regions Covered: North America, Europe, Latin America, Asia-Pacific, Middle East and Africa
Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt
Study Period: 2019 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee
Study Period: 2018 - 2029
Countries Covered: Brazil, Mexico
Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon
Study Period: 2019 - 2029
Countries Covered: Germany, Spain, Italy, France, United Kingdom, Russia
Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon
Study Period: 2018 - 2029
Countries Covered: United States, Canada
Major Players: Novo Nordisk, Glenmark, Novartis, KISSEI, Biocon
Study Period: 2018 - 2029
Countries Covered: Japan, China, South Korea, India, Australia, Malaysia, Indonesia, Philippines, Thailand
Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon
Study Period: 2018 - 2029
Countries Covered: South Africa, Saudi Arabia, Oman, Egypt, Iran
Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon
Study Period: 2019- 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players: Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Sanofi, Biocon
Study Period: 2019 - 2029
Countries Covered: United Kingdom, Germany, France, Italy, Spain, Russia
Major Players: Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca, Biocon
Study Period: 2019- 2029
Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa
Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories
Study Period: 2018 - 2029
Countries Covered: United States, Canada
Major Players: Mylan, Lupin, Merck and Co., Pfizer Inc., Sanofi Aventis
Study Period: 2018 - 2029
Regions Covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.
Filter Reports
By Region
By Countries
